SCHEDULE Filed 2026-01-27 Event 2026-01-23 SEC 0000902664-26-000511 →

Caligan Partners LP → Anika Therapeutics, Inc. ANIK

Stake: 9.95% Shares: 1,435,130 CUSIP: 035255108 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 4.64

349,776 shares short · -16.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $558K

Point72 Asset Mgmt

Post-Filing Returns · since 2026-01-23 on ANIK

+1 day

-0.9%

+5 days

-1.9%

+30 days

+17.3%

+60 days

+53.4%

+90 days

+65.6%

+180 days

+61.2%

Anchor price 9.31 on closest trading day on/after 2026-01-23. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Anika Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2024-05-30	SC	Caligan Partners LP	—	—	view →

Other Filings by Caligan Partners LP

Filed	Form	Issuer	Stake	Shares
2024-05-30	SC	Anika Therapeutics, Inc. ANIK	—	—	view →
2024-01-08	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-07-03	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2023-06-02	SC	EXELIXIS, INC. EXEL	—	—	view →
2022-08-05	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →
2021-12-07	SC	Liquidia Corp LQDA	—	—	view →
2020-11-16	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-10-10	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-09-30	SC	Knowles Corp KN	—	—	view →
2019-09-04	SC	AMAG PHARMACEUTICALS, INC.	—	—	view →
2019-05-09	SC	Knowles Corp KN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →